Skip to main content
Loading
Jennifer Chow

Jennifer Chow

CEO and Managing Director, Chimeric Therapeutics
Canada
Jennifer Chow is the Chief Executive Officer and Managing Director of Chimeric Therapeutics. Jennifer is a cell therapy pioneer and expert with experience developing and commercializing FDA approved CAR T cell therapies, Abecma™, Breyzani™, Yescarta™ and Tecartus™. Jennifer also has experience leading the commercial development for more than 15 pipeline cell therapies. Jennifer joined Chimeric from Kite Pharmaceuticals where she was the Head of Global Marketing, Analytics and Commercial Operations and was responsible for Kite pipeline and portfolio strategy. Prior to Kite, Jennifer was the Global Cell Therapy Commercial Lead at Celgene Corporation defining the global commercial strategy and operating model for Celgene cell therapies. Jennifer has developed over 10 oncology therapeutics for launch and has more than 20 years’ experience in the biotech and pharmaceutical field.
Sessions
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors


 

Media Partner


 

Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.

SIGN UP